Free Trial

Rhythm Pharmaceuticals (RYTM) Institutional Ownership

Rhythm Pharmaceuticals logo
$86.84 -3.68 (-4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$87.08 +0.24 (+0.28%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Rhythm Pharmaceuticals (NASDAQ:RYTM)

Number of
Institutional Buyers
(last 12 months)
183
Total
Institutional Inflows
(last 12 months)
$1.57B
Number of
Institutional Sellers
(last 12 months)
106
Total
Institutional Outflows
(last 12 months)
$45.34B
Get RYTM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rhythm Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RYTM Institutional Buying and Selling by Quarter

Rhythm Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026 Rock Springs Capital Management LP689,748$59.99M3.5%-0.8%1.006%
5/18/2026 Exome Asset Management LLC40,581$3.53M1.8%N/A0.059%
5/16/2026 The Manufacturers Life Insurance Company 50,769$4.42M0.0%-14.8%0.074%
5/16/2026 First Light Asset Management LLC87,181$7.58M0.7%-70.5%0.127%
5/16/2026 SummitTX Capital L.P.165,599$14.40M0.4%+105.1%0.242%
5/16/2026 Lazard Asset Management LLC32,888$2.86M0.0%+28.6%0.048%
5/16/2026 Castleark Management LLC52,279$4.55M0.2%-18.9%0.076%
5/16/2026 Orbimed Advisors LLC314,100$27.32M0.5%+31.0%0.458%
5/15/2026 Granahan Investment Management LLC77,709$6.76M0.3%+45.4%0.113%
5/15/2026 Entropy Technologies LP10,318$897K0.0%+314.0%0.015%
5/14/2026 Renaissance Technologies LLC258,011$22.44M0.0%-24.4%0.376%
5/14/2026 Siren L.L.C.725,511$63.10M1.7%+45.1%1.059%
5/14/2026 Inceptionr LLC4,379$381K0.1%N/A0.006%
5/14/2026 Sei Investments Co.40,685$3.54M0.0%+8.7%0.059%
5/13/2026 First Trust Advisors LP85,506$7.44M0.0%-3.4%0.125%
5/8/2026 PNC Financial Services Group Inc.6,938$603K0.0%+48.9%0.010%
5/7/2026 WCM Investment Management LLC80,620$7.01M0.0%+79.9%0.118%
5/7/2026 Dimensional Fund Advisors LP19,151$1.67M0.0%-40.2%0.028%
5/7/2026 AlphaCentric Advisors LLC9,297$809K0.8%+84.0%0.014%
5/7/2026 Swiss National Bank112,200$9.76M0.0%+0.8%0.164%
5/5/2026 Bank of New York Mellon Corp293,298$25.51M0.0%-2.6%0.428%
5/5/2026 Hillsdale Investment Management Inc.40,300$3.51M0.1%-4.7%0.059%
5/4/2026 Principal Financial Group Inc.5,637$490K0.0%-9.1%0.008%
5/4/2026 Chicago Partners Investment Group LLC3,125$266K0.0%+14.1%0.005%
5/1/2026 Fifth Third Bancorp5,260$457K0.0%N/A0.008%
5/1/2026 Candriam S.C.A.464,340$40.38M0.2%+61.3%0.680%
4/30/2026 Hsbc Holdings PLC14,307$1.23M0.0%N/A0.021%
4/28/2026 Abel Hall LLC4,015$349K0.1%+87.6%0.006%
4/25/2026 Strs Ohio28,914$2.52M0.0%+141.0%0.042%
4/22/2026 Pictet Asset Management Holding SA667,046$57.33M0.1%+8.5%0.977%
4/16/2026 SG Americas Securities LLC18,760$1.63M0.0%+59.8%0.027%
4/16/2026 E. Ohman J or Asset Management AB4,409$383K0.0%-33.1%0.006%
3/17/2026 Rockefeller Capital Management L.P.11,771$1.26M0.0%+32.7%0.017%
2/19/2026 Invesco Ltd.291,150$31.17M0.0%+102.8%0.436%
2/18/2026 Empowered Funds LLC4,164$446K0.0%+94.1%0.006%
2/18/2026 XTX Topco Ltd10,433$1.12M0.0%N/A0.016%
2/18/2026 Voloridge Investment Management LLC60,575$6.48M0.0%-83.6%0.091%
2/18/2026 Virtus Investment Advisers LLC6,017$644K0.2%-14.7%0.009%
2/18/2026 Wellington Management Group LLP250,156$26.78M0.0%+922.0%0.375%
2/18/2026 SummitTX Capital L.P.80,729$8.64M0.3%+580.2%0.121%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/18/2026 Orbimed Advisors LLC239,800$25.67M0.5%+11.5%0.359%
2/18/2026 Opaleye Management Inc.330,000$35.32M4.6%-28.5%0.494%
2/18/2026 Perceptive Advisors LLC2,546,391$272.57M4.9%-99.4%3.816%
2/18/2026 Millennium Management LLC186,709$19.99M0.0%+17.7%0.280%
2/18/2026 Man Group plc9,558$1.02M0.0%-92.6%0.014%
2/18/2026 Janus Henderson Group PLC1,126,125$120.59M0.1%-3.0%1.687%
2/18/2026 Caption Management LLC4,614$494K0.0%-83.3%0.007%
2/18/2026 Cinctive Capital Management LP3,225$345K0.0%-90.8%0.005%
2/18/2026 Balyasny Asset Management L.P.72,282$7.74M0.0%-79.3%0.108%
2/17/2026 Guggenheim Capital LLC12,401$1.33M0.0%+442.7%0.019%
2/17/2026 Logos Global Management LP190,000$20.34M1.2%-5.0%0.285%
2/17/2026ADAR1 Capital Management LLC51,349$5.50M0.4%+3.6%0.077%
2/17/2026 PDT Partners LLC59,436$6.36M0.4%-31.0%0.089%
2/17/2026 AQR Capital Management LLC70,046$7.50M0.0%-12.2%0.105%
2/17/2026 Abel Hall LLC2,140$229K0.1%N/A0.003%
2/17/2026 EFG International AG29,291$3.14M0.1%N/A0.044%
2/17/2026 Lazard Asset Management LLC25,571$2.74M0.0%-15.4%0.038%
2/17/2026 First Light Asset Management LLC295,844$31.67M2.4%+63.9%0.443%
2/17/2026 RA Capital Management L.P.6,666,837$713.62M7.3%+17.3%9.989%
2/17/2026 Quantedge Capital Pte Ltd5,600$599K0.3%-68.5%0.008%
2/17/2026 Jump Financial LLC6,759$723K0.0%N/A0.010%
2/17/2026 Price T Rowe Associates Inc. MD1,560,847$167.07M0.0%+11.5%2.339%
2/17/2026 Rock Springs Capital Management LP695,010$74.39M3.8%-3.1%1.041%
2/17/2026 Integral Health Asset Management LLC475,000$50.84M2.5%+115.9%0.712%
2/17/2026 Adage Capital Partners GP L.L.C.621,585$66.53M0.1%+14.3%0.931%
2/17/2026California State Teachers Retirement System53,537$5.73M0.0%+9.4%0.080%
2/17/2026 Russell Investments Group Ltd.134,180$14.36M0.0%-14.9%0.201%
2/17/2026 Atom Investors LP22,929$2.45M0.2%N/A0.034%
2/17/2026 Granahan Investment Management LLC53,452$5.72M0.2%+7.5%0.080%
2/17/2026 State of Wisconsin Investment Board36,079$3.86M0.0%-11.5%0.054%
2/17/2026 Artisan Partners Limited Partnership263,591$28.22M0.0%+11.3%0.395%
2/17/2026 Fred Alger Management LLC9,301$996K0.0%-24.6%0.014%
2/17/2026 ExodusPoint Capital Management LP75,141$8.04M0.1%N/A0.113%
2/17/2026 Royal Bank of Canada1,676$180K0.0%-98.7%0.003%
2/17/2026 Magnetar Financial LLC29,598$3.17M0.0%N/A0.044%
2/17/2026 Persistent Asset Partners Ltd1,446$155K0.1%N/A0.002%
2/17/2026 Polar Capital Holdings Plc1,185,392$126.88M0.5%-4.8%1.776%
2/16/2026 Squarepoint Ops LLC32,829$3.51M0.0%N/A0.049%
2/16/2026 Sofinnova Investments Inc.271,394$29.05M1.2%+9.9%0.407%
2/16/2026 Verition Fund Management LLC4,504$482K0.0%N/A0.007%
2/16/2026 NEXTBio Capital Management LP67,586$7.23M4.2%N/A0.101%
2/16/2026 Nicholas Investment Partners LP34,710$3.72M0.3%N/A0.052%
2/16/2026 First Turn Management LLC146,303$15.66M1.8%N/A0.219%
2/16/2026 Kennedy Capital Management LLC39,887$4.27M0.1%+0.8%0.060%
2/16/2026 Entropy Technologies LP2,492$267K0.0%-70.7%0.004%
2/16/2026 Arax Advisory Partners381$41K0.0%-51.2%0.001%
2/16/2026 Barclays PLC131,436$14.07M0.0%-7.7%0.197%
2/13/2026 The Manufacturers Life Insurance Company 59,609$6.37M0.0%-2.1%0.089%
2/13/2026 CANADA LIFE ASSURANCE Co5,797$621K0.0%-59.7%0.009%
2/13/2026 Stifel Financial Corp13,247$1.42M0.0%-8.4%0.020%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/13/2026 Smartleaf Asset Management LLC399$43K0.0%+39.5%0.001%
2/13/2026 Morgan Stanley651,402$69.73M0.0%+40.0%0.976%
2/13/2026 Rafferty Asset Management LLC55,526$5.94M0.0%-0.4%0.083%
2/13/2026 First Trust Advisors LP88,505$9.47M0.0%+9.4%0.133%
2/13/2026 Headlands Technologies LLC8,632$924K0.1%N/A0.013%
2/13/2026 Charles Schwab Investment Management Inc.532,447$56.99M0.0%+0.9%0.798%
2/13/2026 Police & Firemen s Retirement System of New Jersey14,183$1.52M0.0%-2.9%0.021%
2/13/2026 State Street Corp2,198,615$235.34M0.0%+8.4%3.294%
2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC549,020$58.77M0.0%+25.5%0.823%
2/13/2026 Wells Fargo & Company MN72,617$7.77M0.0%+54.1%0.109%


RYTM Institutional Ownership - Frequently Asked Questions

During the previous two years, 284 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($713.62M), Vanguard Group Inc. ($664.82M), Primecap Management Co. CA ($372.36M), Baker BROS. Advisors LP ($296.87M), Perceptive Advisors LLC ($272.57M), State Street Corp ($235.34M), and Goldman Sachs Group Inc. ($195.98M).Learn more on Rhythm Pharmaceuticals' institutional investors.

Of the 247 institutional investors that purchased Rhythm Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($2.62M), Westfield Capital Management Co. LP ($1.83M), JPMorgan Chase & Co. ($1.46M), RA Capital Management L.P. ($1.11M), Capital Research Global Investors ($985.09K), Alliancebernstein L.P. ($920.11K), and Price T Rowe Associates Inc. MD ($809.47K).

Institutional investors have bought a total of 16,580,124 shares in the last 24 months. This purchase volume represents approximately $1.57B in transactions.

Of the 106 institutional investors that sold Rhythm Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($416.69M), Primecap Management Co. CA ($2.31M), Balyasny Asset Management L.P. ($579.35K), Westfield Capital Management Co. LP ($560.46K), Marshall Wace LLP ($363.27K), Voloridge Investment Management LLC ($307.69K), and Comerica Bank ($297.65K).

Institutional investors have sold a total of 424,779,872 shares in the last 24 months. This volume of shares sold represents approximately $45.34B in transactions.



This page (NASDAQ:RYTM) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners